In this study, we also observed that the levels of serum CT, CEA, and ProGRP in the MTC group were much higher than those in the non‐MTC malignant tumor and benign thyroid disease groups. This evidence concerns the gene CEACAM5 and medullary thyroid gland carcinoma.